Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Receivables - Other (2019 - 2023)

Historic Receivables - Other for AVITA Medical (RCEL) over the last 5 years, with Q4 2023 value amounting to $30000.0.

  • AVITA Medical's Receivables - Other fell 9665.92% to $30000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $30000.0, marking a year-over-year decrease of 9665.92%. This contributed to the annual value of $56000.0 for FY2024, which is 8666.67% up from last year.
  • According to the latest figures from Q4 2023, AVITA Medical's Receivables - Other is $30000.0, which was down 9665.92% from $201000.0 recorded in Q3 2023.
  • In the past 5 years, AVITA Medical's Receivables - Other registered a high of $3.9 million during Q2 2021, and its lowest value of $30000.0 during Q4 2023.
  • In the last 5 years, AVITA Medical's Receivables - Other had a median value of $441000.0 in 2020 and averaged $846562.5.
  • Its Receivables - Other has fluctuated over the past 5 years, first skyrocketed by 100561.8% in 2021, then tumbled by 9665.92% in 2023.
  • Quarter analysis of 5 years shows AVITA Medical's Receivables - Other stood at $382000.0 in 2019, then grew by 15.18% to $440000.0 in 2020, then dropped by 30.0% to $308000.0 in 2021, then soared by 191.56% to $898000.0 in 2022, then plummeted by 96.66% to $30000.0 in 2023.
  • Its Receivables - Other stands at $30000.0 for Q4 2023, versus $201000.0 for Q3 2023 and $442000.0 for Q2 2023.